Does Rallies show Form 4 insider transactions for MMSI?

Yes. Rallies tracks MMSI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is MMSI research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MMSI. It does not provide personalized investment advice.

MMSI (Merit Medical Systems Inc) Stock Analysis - Insider Trades

Merit Medical Systems Inc (MMSI) is a publicly traded Healthcare sector company. As of May 21, 2026, MMSI trades at $64.49 with a market cap of $3.80B and a P/E ratio of 29.58. MMSI moved +1.13% today. Year to date, MMSI is -27.88%; over the trailing twelve months it is -34.73%. Its 52-week range spans $59.74 to $111.45. Analyst consensus is strong buy with an average price target of $87.50. Rallies surfaces MMSI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading MMSI stock inside the company?

Recent MMSI insider activity includes Smith Christian Adam bought 1.63K, Ward Lynne N. sold 5.00K, Lloyd Brian G. bought 2.00K, Aronson Martha Goldberg bought 2.00K, and Parra Raul Jr. bought 1.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

MMSI Key Metrics

Key financial metrics for MMSI
Metric	Value
Price	$64.49
Market Cap	$3.80B
P/E Ratio	29.58
EPS	$2.17
Dividend Yield	0.00%
52-Week High	$111.45
52-Week Low	$59.74
Volume	0
Avg Volume	0
Revenue (TTM)	$1.52B
Net Income	$128.49M
Gross Margin	48.70%

Recent MMSI Insider Trades

Smith Christian Adam bought 1.63K (~$99.19K) on May 11, 2026.
Ward Lynne N. sold 5.00K (~$313.04K) on May 7, 2026.
Lloyd Brian G. bought 2.00K (~$125.25K) on May 7, 2026.
Aronson Martha Goldberg bought 2.00K (~$120.88K) on May 6, 2026.
Parra Raul Jr. bought 1.50K (~$91.52K) on May 6, 2026.

Latest MMSI News

Merit Medical Q1 Net Income Hits $56.7M, Viewpoint Deal Triples Oncology Market — May 1, 2026
Merit Medical Q1 Revenue Up 7%, GAAP EPS Jumps 39% and Acquires OneMark for $140M — Apr 30, 2026
Merit Medical Acquires View Point Medical for $140M to Expand Oncology Portfolio — Apr 2, 2026
Merit Medical Launches Resilience TTS Esophageal Stent in Three Sizes with Anti-Migration Flanges — Mar 16, 2026
Merit Medical's Forward P/E of 19.05 Beats Straumann's 29.03 — Mar 2, 2026

MMSI Analyst Consensus

10 analysts cover MMSI: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $87.50.

Common questions about MMSI

Who is trading MMSI stock inside the company?: Recent MMSI insider activity includes Smith Christian Adam bought 1.63K, Ward Lynne N. sold 5.00K, Lloyd Brian G. bought 2.00K, Aronson Martha Goldberg bought 2.00K, and Parra Raul Jr. bought 1.50K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for MMSI?: Yes. Rallies tracks MMSI insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MMSI research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MMSI. It does not provide personalized investment advice.